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Introduction
Consultation/liaison (C/L) psychiatry is a subspecialty
that focuses on treating people with mental health dis-
orders that co-exist with medical conditions.[1, 2] As
part of patient evaluations, the C/L psychiatrist relates
to and contends with the issues of others beside the
patient: physicians, nurses, family, visitors, and pa-
tient roommates.[3] Dealing with pain and/or preoc-
cupation with medical concerns, as well as being sur-
rounded by hospital alarms and monitors, creates ad-
ditional obstacles to establishing rapport and empathy.
Patients are often unaware that a psychiatric consul-
tation has been requested; they may wonder whether
their doctor questions their state of mind. The psychia-
trist navigates these obstacles and tries to create an en-
vironment conducive to everyone being cooperative.[1]
This is not easy. The responsibilities of the C/L psy-
chiatrist include evaluations after a suicide attempt or
for suspected suicidal ideation or plans; they also man-
age psychiatric sequelae resulting from medical condi-
tions (e.g., delirium), provide care for pre-existing men-
tal disorders, assess decisional capacity, and treat sub-
stance abuse, including withdrawal states. Providing
liaison and support to the medical and nursing staff is
also important.[4]
In performing a clinical evaluation, the consultant re-
views the medical record and discusses the case with
the referring physician and nursing staff. They as-
sess the patient, review findings and recommenda-
tions with the attending doctor, record documentation,
and set potential follow-up arrangements.[1] Thus,
the psychiatrist assesses the situation and the illness
and/or emotions involved, suggests therapeutic inter-
ventions, and provides coordination.[1] To paraphrase
Sir William Osler, “The physician can cure sometimes,
relieves often, but comforts always.”
The COVID-19 pandemic has created many economic,
psychosocial and mental health difficulties for those af-
fected and for anyone who employs protective mea-
sures such as social isolation, quarantine, and/or
widespread lockdowns.[5, 6]
Psychologic Stressors for COVID-19
Patients
This pandemic has had discomforting implications for
the psychosocial well-being of patients and medical
caregivers. Stressors for those hospitalized for coron-
avirus infections include fear of infecting family and
lost social support coping mechanisms, especially due
to restricted hospital visitation. Pre-existing psychiatric
disorders are often made worse—anxiety and dyspho-
ria emerge with unemployment, school closings, in-
person schooling, and housing problems; many also
mourn loss of intimacy with their doctor due to the use
of personal protective equipment (PPE) or remote com-
munication via electronic devices. Some people com-
plain about sleep deprivation and/or phobias about
not awakening. People also report flashbacks and
nightmares related to procedures such as intubation.
Waiting for COVID-19 test results that may confirm
infection and concern about whether they would be
immune to future infection is also stressful. Oversat-
uration with pandemic-related news is common and
troublesome. Many individuals are worried about sub-
stance abuse relapses, the uncertainty of recovery, and
the fear of dying alone—concern about their uncertain
prognosis and the fear of dying alone are particularly
stressful (see Table 1). The psychiatric consultant must
identify and try to mitigate these concerns while at the
same time managing their own dread about contracting
the illness and continuing to provide support to their
medical colleagues.
ULJRI | https://ir.library.louisville.edu/jri/vol5/iss1/33 1
ULJRI Consultation/Liaison Psychiatry During COVID-19
Table 1. Stressors for patients.
Fear of having exposed family members
Being ill without family visitation
Loss of intimacy with medical caregivers
Fewer coping mechanisms
Worsening past psychiatric disorders





Issues over death and dying
Challenges: Psychiatric Consultant
Maintaining visibility
Like their colleagues, the C/L psychiatrist is con-
cerned with the possibility of being infected and/or
sick with the virus. This might lead a clinician to utilize
telemedicine as their primary means of practice and
to avoid person-to person contact. However, there is
a benefit to having our medical colleagues know that
we too are on the front line of COVID-19 health care.
Visible presence also supports other clinicians and re-
inforces collaborative relationships. When PPE is lim-
ited, supplies must be prioritized to those most directly
involved in close patient contact, but if scarcity is less
of an issue, having the psychiatrist at the bedside lets
other clinicians know: “we are all in this together.”
They serve as good examples to other healthcare work-
ers of the importance of personal care and that it can be
done safely.
Loss of intimacy
“I wish I could see your face,” one patient said to a
consulting psychiatrist; this illustrates one difficulty of
COVID-19 restrictions. Telecommunication is replac-
ing in-person bedside healthcare, adversely affecting
the therapeutic relationship with distractions less no-
ticed at face-to face encounters. Physician instructions
imparted at the bedside may be better followed than
those conveyed by telecommunication. Diminished in-
timacy with a psychiatrist is of particular concern be-
cause patients already feel isolated from family, friends,
co-workers, classmates, religious caregivers, and oth-
ers. Appreciative patients may offer a handshake only
to be reminded that touching is not advisable during
this pandemic. Even with the psychiatrist at the bed-
side, other relationship barriers include masks, face
shields, goggles, gowns, and gloves. This garb conveys
the message, “I must not get close to you.”
Loss of intimacy is worse when caring for elderly peo-
ple, for whom a gentle touch is comforting; they are
often uncomfortable with electronic devices; paranoid
patients are even more suspicious about such instru-
ments. Psychologic effects of decreased intimacy in
caring for individuals with COVID-19 is reminiscent
of the early days of the AIDS epidemic, when a hand-
shake from the physician often precipitated tearfulness
since people were afraid of acquiring HIV through con-
tact.[7, 8] Some helpful interventions to address this
loss of intimacy include gaining permission to enter the
patient’s room, starting the conversation sitting at eye
level, making an effort to ensure privacy, and offering
reassurance that all communication will be done in per-
son.
Managing exacerbation of pre-existing psychiatric
conditions
Anxiety: Most COVID-19-related psychiatric consul-
tations are for management of anxiety, and anxiety dis-
orders were common to many of the affected individu-
als. The most common contributors to patients’ anxiety
are:
1. Concern about prognoses
2. Socio-economic worries
3. Concerns about family members being exposed to
the virus
4. Anxiety caused by restricted visitation policies
5. Suboptimal communication with medical providers
6. Unavailability of established coping methods
7. Fear of not being able to breathe (despite normal
oxygen saturation)
8. Pain
9. Helplessness and loss of control
Patients with COVID-19 exposure and obses-
sive/compulsive disorder struggle with loss of con-
trol and inability to engage in ritualistic behaviors that
were previously stress relievers. Those with panic dis-
orders may become overly focused on somatic symp-
toms, convinced that such panic-related features as
chest tightness, shortness of breath, or rapid heart rate
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Table 2. Challenges for the psychiatrist.
Fear of self-contagion and/or infecting family
Maintaining a hospital presence
Supporting medical and nursing staff
Combating helplessness
Managing pre-existing and/or current psychiatric problems
Watching people die without family presence
Shortages of personal protective equipment
Conveying empathy despite telecommunication
Combating stigmatization of patients infected by COVID-19
Dealing with substance use issues
Assessing decisionality for COVID-19 patients
Attending to self care
are dangerous harbingers of deteriorating health. In-
dividuals with claustrophobia beg not to be confined
to their room with doors closed. Some people evi-
dence acute stress and/or post-traumatic stress disor-
ders with nightmares and flashbacks related to events
such as intubation. Individuals with sleep disorders
sometimes develop a sleep phobia, with fear of death
during the night; sleep deprivation can worsen their
overall status and lead to delirium.
Patients with anxiety disorders and COVID-19 infec-
tions may become worse when prescribed a corticos-
teroid or sympathomimetic drug. Pulmonary status
may limit the prescribing of pharmacotherapies, such
as benzodiazepines; those previously taking them must
be monitored for withdrawal. For mild anxiety symp-
toms, antihistamines are often employed, but their ap-
plication for older people increases the risk of delirium.
Dexmedetomidine is often prescribed to calm severe
anxiety or agitation unresponsive to other medications.
Anxiety is expected among people suffering from a dis-
ease about which little is known. Persons with pre-
existing anxiety are likely to have more intense emo-
tional responses. The challenge in caring for these
patients includes providing psychotherapies that em-
power them and promote autonomy. Open communi-
cation between patients and medical caregivers is usu-
ally reassuring. When able to ask questions of their
providers, individuals can combat helplessness and
feeling out of control. In providing care for such anx-
ious persons, the C/L psychiatrist should:
1. Provide psychotherapy to empower active partici-
pation in medical care.
2. Be a patient advocate regarding issues such as pain
control.
3. Encourage them to be grateful for incremental
progress.
4. Support and debrief nurses to improve interactions,
especially for staff who are anxious, stressed, inex-
perienced, and/or fearful of contagion.
5. Employ pharmacotherapies and behavioral inter-
ventions.
6. Utilize persons who have recovered from COVID-19
illness as peer supporters.
Depression: “I’m not suicidal,” a depressed patient
told a psychiatrist, “but I hope to die from COVID.”
Depression is a common reason for psychiatric consul-
tations. Dysphoria is more intense among those with
previous mood disorders. They often express concern
about family members getting sick and missing their
presence at the bedside. Many were already despon-
dent because of unemployment and financial concerns.
While people rarely express suicide intent solely re-
lated to COVID-19 positivity, some report conditional
suicidal thoughts, such as “if I have to live with this
pain, I’ll just kill myself.” Some of them require con-
tinuous, one-to-one, direct observation to prevent self-
harm; this creates additional stress for the patient, the
psychiatrist, and staff, since a staff member must be
present to monitor the person for a prolonged time. The
psychiatrist may be conflicted about ordering such ob-
servation for fear of putting hospital personnel at in-
fection risk. Mitigating depression is complicated since
antidepressant medications often have a delayed on-
set of action. Some have drug interactions and anti-
cholinergic effects, which might produce a delirium.
Some seriously ill patients might be intubated, pre-
cluding oral intake. Psychostimulant drugs such as
methylphenidate are occasionally indicated because of
a more immediate onset of action.[9]
Another challenging issue is the management of de-
pressed COVID-19-positive patients who are medically
stable but in need of psychiatric hospitalization. Some
mental health facilities have opened COVID-19 wards,
making continuity of care possible. During this pan-
demic, psychiatrists often treat depressed COVID-19-
positive persons with supportive psychotherapy de-
signed to maintain hope, celebrate signs of progress,
and develop new coping strategies. The consistent
presence of a supportive, non-judgmental caregiver can
substantially elevate mood.
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Substance abuse disorders: A damaging conse-
quence of this pandemic is its influence facilitating sub-
stance abuse disorders.[10] Many people have a tenu-
ous grip on sobriety, so decreased support, less social
connection, and financial shortage are dangerous risk
factors for drug relapse. Chemical dependency makes
all aspects of medical services more complicated. The
absence of in-person therapeutic systems, such as Al-
coholics or Narcotics Anonymous meetings, and per-
sonal encounters with sponsors can have devastating
consequences, including relapse and overdose. Some
COVID-19 patients with chemical dependency com-
plain of stigmatization by medical or nursing staff, and
this loss of trust makes healthcare delivery more dif-
ficult. In such circumstances, advocating on behalf of
patients and discussing clinical frustrations with the
medical team is often helpful. For anyone with history
of opiate abuse, analgesic dosages may require adjust-
ment due to high tolerance. The use of buprenorphine
can be helpful in managing pain while also prevent-
ing opiate withdrawal. In general, the prescription of
controlled pharmaceuticals increases the likelihood of
drug relapse after discharge. The consultant should
therefore minimize prescription of potentially addic-
tive agents for such conditions as anxiety and sleep dif-
ficulties.
Poor coping skills, a desire for immediate gratification,
disrupted family relationships, and isolation-induced
lonesomeness and boredom are other issues that must
be addressed. While intoxicated, inappropriate behav-
ior may have occurred, for which the patient, once
sober, feels guilt. Some patients may wish to apologize
for certain actions. Such concerns were heightened by
the pandemic since stress levels were higher, and sub-
stance abuse issues were more prevalent. Open discus-
sion should provide some comfort. Treatment for drug
dependence, possibly with family counseling, should
always be provided as well. Psychiatrists should have
some knowledge of relapse warning signs and make
use of such individuals as harm reduction healthcare
personnel, many of whom are themselves in recovery.
Hospital chaplains are beneficial, especially when there
are spiritual issues.
Delirium: Delirium can be caused by infections,
metabolic derangement, hypoxemia, sleep deprivation,
pain, medicinal effects, drug withdrawal, postopera-
tive complications, cerebrovascular events, intensive
care unit sensory overload, and for people with demen-
tia, being in an unfamiliar environment. Psychiatrists
often manage patient behavior associated with these is-
sues while the medical team investigates and/or treats
the underlying ailment.[11] Many of these conditions
complicate COVID-19 patient care. Evidence for cen-
tral nervous system pathology induced by coronavirus
infection is inconclusive with regard to predisposition
for and persistence of neurologic features.[12]
COVID-19-mandated restrictive family visitation poli-
cies are another burden; contact with relatives could
mitigate the need for pharmacotherapies.[13] Manage-
ment of patients with delirium emphasizes having a fa-
miliar environment for patients, but this is difficult to
provide in this pandemic era. Nocturnal accentuation
of confusion (“sundowning”) often leads to sleep de-
privation, which can intensify delirium, and electronic
communication devices can cause discomfort for older
persons and anyone who is already psychotic or para-
noid.[14] Patients with encephalopathy evidence more
comfort when family or a familiar person are at the bed-
side. The consistent presence of the psychiatrist pro-
vides greater stability, too. Finally, the consultant may
have to determine decisionality for COVID-19 patients
who refuse treatment or insist on leaving the hospital
against medical advice. In these instances, they must
balance patient rights against the potential threat to so-
ciety posed by a COVID-19-positive patient who might
not possess the cognitive ability or judgment to comply
with social distancing, mask wearing, and other pre-
ventive measures. Care of a COVID-19 patient with
cognitive impairment represents a significant challenge
for the consulting psychiatrist.
Maintaining staff morale: Morale is a concern par-
ticularly among nurses. Beyond caring for critically ill
patients, they must cope with COVID-19-related issues,
such as repeated calls from family members unable to
visit, increased workloads, and shortages of PPE. Staff
shortages result from personnel who are ill or quaran-
tined. It is demoralizing to care for critically ill patients
who seek medical care late in their course of illness due
to COVID-19 infection fears. Healthcare workers thus
experience frustration while being overworked and
emotionally taxed. The psychiatrist should spend time
with the hospital staff, exploring their issues through
debriefing and discussion. Making appreciative com-
ments about dedicated service and inquiring about the
health and well-being of family members reaps a social
dividend; it also improves all hospital and patient in-
teractions. This is especially important for anyone pro-
viding care for cognitively impaired patients who may
be non-compliant, verbally abusive, or combative. The
simple question, “What’s been your experience taking
care of this patient?” can lead to a conversation that
significantly boosts morale. Improving the quality of
healthcare by attending to staff morale secondarily also
promotes the psychiatrist’s sense of well-being.
Combating helplessness: Psychiatrists are not alone
in feeling helplessness about this disease. There is
agony in watching patients die, especially if they are
alone.[13] There is limited understanding about the ad-
verse effects or interactions of psychiatric medications
co-prescribed with antiviral agents, such as remdesivir.
Fear of personally becoming ill and potentially infect-
ing family members creates stress and helplessness.
“I am afraid of taking this illness home to my fam-
ULJRI | https://ir.library.louisville.edu/jri/vol5/iss1/33 4
ULJRI Consultation/Liaison Psychiatry During COVID-19
ily,” is often heard.[15] Shortages of, or not trusting
in, PPE and impersonal means of communicating also
contribute. Pulmonologists, critical care, and infectious
diseases physicians are not immune to these feelings,
so one should not assume that they are.
Usually, returning home offers a respite from pa-
tient care worries; however, COVID-19 care providers
prominently maintain the fear that they might convey
a viral infection to those at home. Balancing a sense
of obligation to provide care for hospitalized patients
while wanting to protect family creates a dilemma for
all physicians, including the mental health caregiver.
The psychiatrist should focus on fixable things. Ex-
amples include improving communication between pa-
tients and caregivers, reassuring physicians and pa-
tients by her presence, alleviating patients’ mental is-
sues, being up to date on COVID-19 matters, attempt-
ing to improve the quality of whatever life remains, of-
fering hope and combating pessimism, and realizing
that she is not alone in her feelings of powerlessness
with regard to this pandemic. Once back home, it is
important to maintain protective precautions such as
frequent handwashing, leaving shoes and outer gar-
ments outside, changing into clean clothing, and isolat-
ing when indicated. To avoid physician burnout, main-
taining routines of a healthy diet, regular exercise, and
avoiding substance use is important. Utilizing spiritual
advisors, maintaining sleep, and taking vacations or
time off also help.[16] In combating pandemic-related
helplessness, the consulting psychiatrist will be well
served to accept the things he cannot change, change
the things he can, and acquire the wisdom to know the
difference.
Conclusion
Providing psychiatric consultation for someone in-
fected by COVID-19 is similar to treating hospital-
ized patients with any medical or psychiatric condition.
There are, however, circumstances created by this pan-
demic that are unique; the psychiatrist ought to recog-
nize these issues and respond while attending to their
own frustrations. Providing good professional work
and appropriate self-care is key. Doing so and being ap-
preciative of clinical progress can empower physicians
and everyone involved.
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